SCHEMBL4478743

SCHEMBL4478743

Cc1[nH]c(C)c(-c2c[nH]c(-c3ccc(Cl)cc3)cc2=O)c(=O)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.42
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 3/20 0.39
PDE10A Q9Y233 2/20 0.39
BRD4 O60885 2/20 0.39
ALDH1A1 P00352 4/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
THRB P10828 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.34
CXCL12 P48061 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
CRHBP P24387 1/20 0.33
HTT P42858 1/20 0.33
CRHR2 Q13324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4475367 0.90 ADORA2A (0.39) SLC2A1KMT2AMEN1NPC1RAB9A
SCHEMBL4490544 0.88 BRD4 (0.39) KMT2AMEN1NPC1RAB9ABRD4
SCHEMBL4481795 0.88 ALDH1A1 (0.43) SLC2A1KMT2AMEN1NPC1RAB9A
SCHEMBL3392240 0.88 PRKAB2 (0.36) SLC2A1KMT2AMEN1NPC1RAB9A
SCHEMBL4487870 0.87 SLC2A1 (0.40) SLC2A1KMT2AMEN1NPC1RAB9A
SCHEMBL4483594 0.87 MEN1 (0.31) SLC2A1KMT2AMEN1NPC1RAB9A
SCHEMBL4474681 0.85 SLC2A1 (0.37) SLC2A1NPC1RAB9AKDM4EALDH1A1
SCHEMBL4480531 0.84 CTSV (0.47) SLC2A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL4490716 0.84 SCN10A (0.37) SLC2A1
Hydrochloric Acid SCHEMBL4489667 0.83 SCN10A (0.36) SLC2A1KDM4ECRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US claimed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US claimed
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP SLC2A1 2278/4885KMT2A 3141/4885MEN1 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.